Navigation

  • Skip to Content
Toggle main navigation
  • Euskara
  • Español
  • English
  • Campus of Araba
  • Campus of Biscay
  • Campus of Gipuzkoa
  • Login
  • Euskara
  • Español
  • English
  • Campus of Araba
  • Campus of Biscay
  • Campus of Gipuzkoa
  • Profiles
  • Studies
  • Structure
  • Research
  • University access
  • Thematic areas
  • Services
  • Directory
University of the Basque Country

Neuropsychopharmacology Research Group

  • Profiles
  • Studies
  • Structure
  • Research
  • University access
  • Thematic areas
  • Services
  • Directory
Search
  1. UPV/EHU
  2. Research
  3. Neuropsychopharmacology Research Group
  4. Activities
  5. Patents
  6. Synthetic I2 imidazoline receptor ligands for prevention or treatment of human brain
Neuropsychopharmacology Research Group

Neuropsychopharmacology Research Group

Menu Toggle site navigation
  • Research Group Show/hide subpages
    • Introduction
    • Senior Researchers
    • PhD Students
    • Technical and administrative staff
    • Visiting researchers
    • Current collaborations
    • Collaboration with companies
    • Former lab members
  • Research Profile Show/hide subpages
    • Research activities
    • Available techniques
  • Activities Show/hide subpages
    • Research projects
    • Scientific publications
    • Doctoral thesis
    • Master thesis
    • Degree final projects
    • Patents
    • Seminars
    • Participation in postgraduate masters
    • Colaboration in doctorate programme
    • Awards and distinctions

Patents

Back

Synthetic I2 imidazoline receptor ligands for prevention or treatment of human brain

Type:
Patent
Researcher(s):
M.C. Escolano, M. Pallás, C.G. Griñán, S. Abás, L.F. Callado and J.A. García-Sevilla
Year:
2019
Description:

International Publication Number WO 2019/121853 A1

  • Accessibility
  • Legal information
  • Contact
  • Sitemap
  • Help

UPV/EHU